Literature DB >> 19573808

EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt.

Hui Miao1, Da-Qiang Li, Amitava Mukherjee, Hong Guo, Aaron Petty, Jennifer Cutter, James P Basilion, John Sedor, Jiong Wu, David Danielpour, Andrew E Sloan, Mark L Cohen, Bingcheng Wang.   

Abstract

Both pro- and antioncogenic properties have been attributed to EphA2 kinase. We report that a possible cause for this apparent paradox is diametrically opposite roles of EphA2 in regulating cell migration and invasion. While activation of EphA2 with its ligand ephrin-A1 inhibited chemotactic migration of glioma and prostate cancer cells, EphA2 overexpression promoted migration in a ligand-independent manner. Surprisingly, the latter effects required phosphorylation of EphA2 on serine 897 by Akt, and S897A mutation abolished ligand-independent promotion of cell motility. Ephrin-A1 stimulation of EphA2 negated Akt activation by growth factors and caused EphA2 dephosphorylation on S897. In human astrocytoma, S897 phosphorylation was correlated with tumor grades and Akt activation, suggesting that the Akt-EphA2 crosstalk may contribute to brain tumor progression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19573808      PMCID: PMC2860958          DOI: 10.1016/j.ccr.2009.04.009

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  55 in total

1.  Multiple in vivo tyrosine phosphorylation sites in EphB receptors.

Authors:  M S Kalo; E B Pasquale
Journal:  Biochemistry       Date:  1999-10-26       Impact factor: 3.162

Review 2.  Eph receptors and ephrin ligands: embryogenesis to tumorigenesis.

Authors:  V C Dodelet; E B Pasquale
Journal:  Oncogene       Date:  2000-11-20       Impact factor: 9.867

3.  Receptor tyrosine kinase EphA2 is regulated by p53-family proteins and induces apoptosis.

Authors:  M Dohn; J Jiang; X Chen
Journal:  Oncogene       Date:  2001-10-04       Impact factor: 9.867

4.  In vivo tyrosine phosphorylation sites of activated ephrin-B1 and ephB2 from neural tissue.

Authors:  M S Kalo; H H Yu; E B Pasquale
Journal:  J Biol Chem       Date:  2001-07-20       Impact factor: 5.157

5.  Akt mediates Rac/Cdc42-regulated cell motility in growth factor-stimulated cells and in invasive PTEN knockout cells.

Authors:  M Higuchi; N Masuyama; Y Fukui; A Suzuki; Y Gotoh
Journal:  Curr Biol       Date:  2001-12-11       Impact factor: 10.834

6.  Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production.

Authors:  D Kim; S Kim; H Koh; S O Yoon; A S Chung; K S Cho; J Chung
Journal:  FASEB J       Date:  2001-09       Impact factor: 5.191

7.  Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway.

Authors:  H Miao; B R Wei; D M Peehl; Q Li; T Alexandrou; J R Schelling; J S Rhim; J R Sedor; E Burnett; B Wang
Journal:  Nat Cell Biol       Date:  2001-05       Impact factor: 28.824

8.  EphA2 overexpression causes tumorigenesis of mammary epithelial cells.

Authors:  D P Zelinski; N D Zantek; J C Stewart; A R Irizarry; M S Kinch
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

9.  Akt1 induces extracellular matrix invasion and matrix metalloproteinase-2 activity in mouse mammary epithelial cells.

Authors:  B K Park; X Zeng; R I Glazer
Journal:  Cancer Res       Date:  2001-10-15       Impact factor: 12.701

Review 10.  Eph/ephrin signaling in epithelial development and homeostasis.

Authors:  Hui Miao; Bingcheng Wang
Journal:  Int J Biochem Cell Biol       Date:  2008-08-09       Impact factor: 5.085

View more
  211 in total

1.  Cancer cells exploit the Eph-ephrin system to promote invasion and metastasis: tales of unwitting partners.

Authors:  Bingcheng Wang
Journal:  Sci Signal       Date:  2011-05-31       Impact factor: 8.192

2.  EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy.

Authors:  Joachim Lupberger; Mirjam B Zeisel; Fei Xiao; Christine Thumann; Isabel Fofana; Laetitia Zona; Christopher Davis; Christopher J Mee; Marine Turek; Sebastian Gorke; Cathy Royer; Benoit Fischer; Muhammad N Zahid; Dimitri Lavillette; Judith Fresquet; François-Loïc Cosset; S Michael Rothenberg; Thomas Pietschmann; Arvind H Patel; Patrick Pessaux; Michel Doffoël; Wolfgang Raffelsberger; Olivier Poch; Jane A McKeating; Laurent Brino; Thomas F Baumert
Journal:  Nat Med       Date:  2011-04-24       Impact factor: 53.440

Review 3.  Mechanisms of ephrin-Eph signalling in development, physiology and disease.

Authors:  Artur Kania; Rüdiger Klein
Journal:  Nat Rev Mol Cell Biol       Date:  2016-01-21       Impact factor: 94.444

Review 4.  Eph receptors and ephrins in cancer: bidirectional signalling and beyond.

Authors:  Elena B Pasquale
Journal:  Nat Rev Cancer       Date:  2010-03       Impact factor: 60.716

5.  EphB3 suppresses non-small-cell lung cancer metastasis via a PP2A/RACK1/Akt signalling complex.

Authors:  Guo Li; Xiao-Dan Ji; Hong Gao; Jiang-Sha Zhao; Jun-Feng Xu; Zhi-Jian Sun; Yue-Zhen Deng; Shuo Shi; Yu-Xiong Feng; Yin-Qiu Zhu; Tao Wang; Jing-Jing Li; Dong Xie
Journal:  Nat Commun       Date:  2012-02-07       Impact factor: 14.919

Review 6.  Essential roles of EphB receptors and EphrinB ligands in endothelial cell function and angiogenesis.

Authors:  Ombretta Salvucci; Giovanna Tosato
Journal:  Adv Cancer Res       Date:  2012       Impact factor: 6.242

Review 7.  Therapeutic targeting of EPH receptors and their ligands.

Authors:  Andrew W Boyd; Perry F Bartlett; Martin Lackmann
Journal:  Nat Rev Drug Discov       Date:  2014-01       Impact factor: 84.694

Review 8.  Eph receptor signaling and ephrins.

Authors:  Erika M Lisabeth; Giulia Falivelli; Elena B Pasquale
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-09-01       Impact factor: 10.005

Review 9.  Eph receptor tyrosine kinases in cancer stem cells.

Authors:  Jin Chen; Wenqiang Song; Katherine Amato
Journal:  Cytokine Growth Factor Rev       Date:  2014-05-17       Impact factor: 7.638

10.  Epigenetic silencing of HOPX promotes cancer progression in colorectal cancer.

Authors:  Hiroshi Katoh; Keishi Yamashita; Mina Waraya; Ofer Margalit; Akira Ooki; Hideaki Tamaki; Hiroyuki Sakagami; Kenichi Kokubo; David Sidransky; Masahiko Watanabe
Journal:  Neoplasia       Date:  2012-07       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.